BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18346168)

  • 1. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
    Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Zhang XJ; Xiong ZB; Tang AL; Ma H; Ma YD; Wu JG; Dong YG
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):156-61. PubMed ID: 19566839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels.
    Nishida H; Sato T; Miyazaki M; Nakaya H
    Cardiovasc Res; 2008 Jan; 77(2):398-405. PubMed ID: 17706952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
    Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
    Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
    Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
    Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postconditioning inhibits mitochondrial permeability transition.
    Argaud L; Gateau-Roesch O; Raisky O; Loufouat J; Robert D; Ovize M
    Circulation; 2005 Jan; 111(2):194-7. PubMed ID: 15642769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
    Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
    J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
    Davidson SM; Hausenloy D; Duchen MR; Yellon DM
    Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
    Bullard AJ; Govewalla P; Yellon DM
    Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
    Miki T; Miura T; Hotta H; Tanno M; Yano T; Sato T; Terashima Y; Takada A; Ishikawa S; Shimamoto K
    Diabetes; 2009 Dec; 58(12):2863-72. PubMed ID: 19755525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia-induced cardioprotection is potentiated by ischemic postconditioning in rats.
    Murozono Y; Takahashi N; Shinohara T; Ooie T; Teshima Y; Hara M; Saikawa T; Yoshimatsu H
    Exp Biol Med (Maywood); 2009 May; 234(5):573-81. PubMed ID: 19234055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.